Mark Casale
Analyst · Barclays. Your line is open
Yes. I mean, I think in terms of the costs, we don't get too caught up in the cost. I mean, the cost of capital is pretty good. But those - that pricing will ebb and flow, just like it will for equity and for debt. I think it's really around the loss mitigation. So remember the capital, since the term is four to five years, is somewhat fleeting, it's a little bit more like debt. It is not permanent capital, like equity. So the real key to the CRT, Mark, in addition to the capital relief, which is material, is really the hedging of the risk. So now when we say our expected loss for the '17 book, and we always say kind of claims rate, 2% to 3%, we're pretty much hedged - we're hedged against that up until the first kind of 2.25%. We retain the first 2.25% and then from 2.25% up to a certain detachment, we're covered, that's pretty significant. And remember, as folks said, the industry is a little bit of a binary, kind of boom or bust. And by removing kind of that mezzanine part of the capital structure, we've really started to reduce the forward volatility around credit. And again, I think that's important. Not really appreciated yet, I think, by the market given the focus on pricing. But I think, over time, we're seeing the MI business continue to evolve where we would hold the equity layer of the transaction and, obviously, keep the catastrophic part and then tower out the mezzanine piece. And again, it's significant going forward. It will be appreciated over time, but, to me, that was the biggest news of the quarter. And again will - and that's something we'll continue to look out down the road.